MindWalk Holdings (HYFT) Exchange Rate Effect (2023 - 2026)
MindWalk Holdings (HYFT) posted quarterly Exchange Rate Effect of -$14590.1 for Q2 2026, up 96.52% year-over-year from -$7424.2 in Q2 2025, and up 94.73% quarter-over-quarter from -$276698.8 in Q1 2026.
Powered by 
Analysis
MindWalk Holdings (HYFT) Exchange Rate Effect (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Exchange Rate Effect for 4 consecutive years, with -$14590.1 the latest figure, recorded in Q2 2026.
- In Q2 2026, Exchange Rate Effect rose 96.52% year-over-year to -$14590.1; the TTM figure through Apr 2026 stood at -$370191.9 (down 17.37% YoY), while the FY2026 annual figure was -$374966.1, down 19.25% from the prior year.
- Exchange Rate Effect improved to -$14590.1 in Q2 2026 per HYFT's latest filing, from -$276698.8 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $432737.1 in Q1 2024 and bottomed at -$894612.1 in Q2 2024.
- Historically, Exchange Rate Effect has averaged -$89264.3 across 4 years, with a median of -$76337.6 in 2023.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 7665.57% — and 2025, when it surged 136.65%.
- MindWalk Holdings' Exchange Rate Effect stood at -$50887.1 in 2023, then slumped by 100.03% to -$101788.1 in 2024, then slipped by 18.27% to -$120386.8 in 2025, then surged by 87.88% to -$14590.1 in 2026.
- Business Quant data shows HYFT's Exchange Rate Effect at -$14590.1 in Q2 2026, -$276698.8 in Q1 2026, and -$120386.8 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -287,000.00 |
| 10 | MindWalk Holdings | 61.69 Mn | 53.41 Mn | 1.82 Mn | -21,155.67 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -21,155.67 |
| Jan 31, 2026 | 294,713.01 |
| Oct 31, 2025 | -64,879.11 |
| Jul 31, 2025 | 29,839.20 |
| Apr 30, 2025 | 325,363.38 |
| Jan 31, 2025 | 123,274.70 |
| Oct 31, 2024 | -125,221.37 |
| Jul 31, 2024 | 113,198.36 |
| Apr 30, 2024 | -75,964.59 |
| Jan 31, 2024 | 51,040.78 |
| Oct 31, 2023 | -47,199.61 |
| Jul 31, 2023 | 84,660.03 |
| Apr 30, 2023 | 4,434.30 |
| Jan 31, 2023 | -414,439.48 |